Abstract:Objective To explore the relationship between p38-mitogen activated protein kinase (p38MAPK) signaling pathway and high glucose-induced hepatic stellate cell (HSC) activation.Methods HSC was cultivated,and morphological identification was conducted.Twenty human HSC samples were randomly collected to represent each experimental group including the control group,high glucose group and blocking group.Cells from the control group were cultured under normal conditions.Cells from the high glucose group were cultured under high glucose conditions of which the ultimate concentration was 25mol/L.The blocking group was cultured under high glucose conditions in the presence of the p38MAPK inhibitor SB203580 of which the ultimate concentration was 40mol/L.After incubation for 120 h,SABC and Western blot analysis were used to detect α-SMA expression in each sample to determine the degree of hepatic stellate cell activation.Western blot analysis was also used to detect the expression of phosphop38MAPK protein in each group.Results According to identification,the cultured HSC was flat with big cell body,and had well-developed stress fiber.There was less fat droplet in the cytoplasm.The result of SABC situ test showed that,compared with the high glucose group,positive signal of α-SMA proteins was stronger than that of control group which had similar positive signal as the blocking group.The differences of both HSCα-SMA and p-p38MAPK protein expression levels in three groups had statistical significance (F=31.36,78.49,P all＜0.01).Among them,the expression level of α-SMA in the high glucose group was (34.61 ±4.07) ％ and higher than (23.90±6.02) ％ of control group and (26.48±4.41)％ of blocking group,of which the differences were statistically significant (t=-7.20 and-5.37,P both ＜0.01).The expression level ofp-p38MAPK was (22.79±3.80)％ in the high glucose group,(8.13±4.95)％ in the control group and (10.66±4.15)％ in the blocking group,of which the differences had statistical significance (t=-11.01 and-10.41,P both ＜0.01).Conclusion The higher level of HSC represents the higher signal strength of p38MAPK.However,blocking the p38MAPK signaling pathway can reduce the activation of hepatic stellate cells.

The inhibiting effect of galanin on activation state of hepatic stellate cells mediated through type 2 galanin receptor

Newly expressed galanin type 2 receptor suppresses proliferation of activated hepatic stellate cells

Galanin Receptor 2 Mediates Antifibrogenic Effects of Galanin on Hepatic Stellate Cells

Relationship Between High Glucose-Induced Hepatic Stellate Cell Activation and the P38mapk Signaling Pathway

GLP-1 receptor activation effects the p38MAPK signal pathway in hepatic stellate cells]

The GABAB Receptor Inhibits Activation of Hepatic Stellate Cells

[The Effect of Ligand of Peroxisome Proliferators-Activated Receptor Gamma 15D-Pgj2 on the Proliferation and Activation of Hepatic Stellate Cells].

The Effect of Somatostatin Analogue on Expression of Connective Tissue Growth Factor Gene of Rat Hepatic Stellate Cells

Effect of interfering RNA targeting high mobility group box chromosomal protein 1 on the biological characters of hepatic stellate cells

[Effects of Galectin-3 on Proliferation and Apoptosis of Hepatic Stellate Cells].

Effects of CTGF on Kupffer Cells Induced Activation of Hepatic Stellate Cells

[Effect of Protein Kinase C/transforming Growth Factor Beta 1 Pathway on Activation of Hepatic Stellate Cells].

Effect of silencing connective tissue growth factor by small interfering RNA on culture-activated rat hepatic stellate cells

Characterization and Sub-cellular Localization of GalNAc-Binding Proteins Isolated from Human Hepatic Stellate Cells.

Regulation of Hepatic Stellate Cell Activation and Proliferation by Hedgehog Signal Pathway

Effects of the Tyrosine Protein Kinase Inhibitor Genistein on the Proliferation, Activation of Cultured Rat Hepatic Stellate Cells.

Rosiglitazone depresses activation of rat hepatic stellate cells in vitro

Effects of siRNA targeting DDR2 on hepatic stellate cells

[Regulation of Hepatic Stellate Cell Activation by Interleukin-10/Platelet Derived Growth Factor/mitogen-Activated Protein Kinase Pathway].

TGF-β1 activates mouse hepatic stellate cells through Jagged1/Notch

Inhibitory Effect of Human Interferon‐beta‐1a on Activated Rat and Human Hepatic Stellate Cells